New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

HUMIRA® (adalimumab) injection, for subcutaneous use

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call at 9891296838 or Email to discuss.

Facts of Humira (adalimumab)

HUMIRA® (adalimumab) injection, for subcutaneous use
Initial U.S. Approval: 2002
Generic Name: adalimumab
Company: AbbVie
Mechanism of Action: Anti-tumour necrosis factor alpha (TNFa) MAb
Initial U.S. Approval: 2002
• 40 mg/0.8 mL in a single-use prefilled pen (HUMIRA Pen)
• 40 mg/0.8 mL in a single-use prefilled glass syringe

South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Humira (adalimumab)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Humira (adalimumab) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:

Query Form


What Humira is?

Adalimumab, sold under the brand name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Use is generally only recommended in people who have not responded to other treatments. It is used by injection under the skin.

What adalimumab is?

Like other TNF inhibitors, it is an immunosuppressive medication, used to treat autoimmune diseases such as rheumatoid arthritis.
Adalimumab is administered by subcutaneous injection.[5][3] For most indications, the maintenance treatment is an injection every other week.
In the US, adalimumab is indicated for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult crohn’s disease, pediatric crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

In the EU it is indicated for the treatment of:

  • plaque psoriasis (a disease causing red, scaly patches on the skin);
  • psoriatic arthritis (a disease causing red, scaly patches on the skin with inflammation of the joints);
  • rheumatoid arthritis (a disease causing inflammation of the joints);
  • axial spondyloarthritis (inflammation of the spine causing back pain), including ankylosing spondylitis and when X-ray does not show disease but there are clear signs of inflammation;
  • polyarticular juvenile idiopathic arthritis and active enthesitis-related arthritis (both rare diseases causing inflammation in the joints);
  • Crohn’s disease (a disease causing inflammation of the gut);
  • ulcerative colitis (a disease causing inflammation and ulcers in the lining of the gut);
  • hidradenitis suppurativa (acne inversa), a long-term skin disease that causes lumps, abscesses (collections of pus) and scarring on the skin;
  • non-infectious uveitis (inflammation of the layer beneath the white of the eyeball).

Related Products